LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.68 | 21.74 | 4532 | 3418 | 1.3256 | 1.0788 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 43.65 | 21.74 | 1841 | 3754 | 0.4904 | 0.8172 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 43.65 | 21.74 | 3943 | 3754 | 1.0503 | 1.0132 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 43.65 | 21.74 | 4852 | 3754 | 1.2924 | 1.0702 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 43.65 | 21.74 | 4991 | 3754 | 1.3294 | 1.0781 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 45.62 | 21.74 | 2378 | 4150 | 0.5729 | 0.8582 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 45.62 | 21.74 | 4340 | 4150 | 1.0456 | 1.0118 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 45.62 | 21.74 | 5203 | 4150 | 1.2535 | 1.0605 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 45.62 | 21.74 | 5378 | 4150 | 1.2956 | 1.0695 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 47.59 | 21.74 | 2125 | 4492 | 0.4731 | 0.8145 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 47.59 | 21.74 | 4736 | 4492 | 1.0543 | 1.0138 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 47.59 | 21.74 | 5620 | 4492 | 1.2511 | 1.0591 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 47.59 | 21.74 | 5777 | 4492 | 1.2860 | 1.0665 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 49.56 | 21.74 | 2322 | 4838 | 0.4799 | 0.8203 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 49.56 | 21.74 | 5097 | 4838 | 1.0534 | 1.0134 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 49.56 | 21.74 | 5964 | 4838 | 1.2325 | 1.0543 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 49.56 | 21.74 | 6141 | 4838 | 1.2691 | 1.0621 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 51.53 | 21.74 | 2203 | 5150 | 0.4277 | 0.7959 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 51.53 | 21.74 | 5571 | 5150 | 1.0816 | 1.0200 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 51.53 | 21.74 | 6163 | 5150 | 1.1965 | 1.0460 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 51.53 | 21.74 | 6549 | 5150 | 1.2715 | 1.0618 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.50 | 21.74 | 2054 | 5425 | 0.3786 | 0.7703 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.50 | 21.74 | 5964 | 5425 | 1.0992 | 1.0239 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.50 | 21.74 | 6226 | 5425 | 1.1475 | 1.0348 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.50 | 21.74 | 6942 | 5425 | 1.2794 | 1.0629 | MN20160310_N01 | J07 |